KATHERINE WEEKS: Open Payments
NPI 1124672514 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 45 payments from 10 companies in 2025. Trend: 2023 $611 · 2024 $1,074 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $354 |
| Otsuka America Pharmaceutical, Inc. | 8 | $348 |
| Janssen Pharmaceuticals, Inc | 7 | $224 |
| Vanda Pharmaceuticals Inc. | 3 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Lundbeck LLC | 1 | $27 |
| Alkermes, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
Products named: VRAYLAR, REXULTI, SPRAVATO, ABILIFY ASIMTUFII, HETLIOZ, CAPLYTA, TRINTELLIX, COBENFY.
Industry payments across CA — which companies pay providers there.
